Epigenetic silencing of the sulfotransferase 1A1 gene by hypermethylation in breast tissue

Oncology Reports

Volumn 15, Issue 1, 2006, Pages 27-32

  Kwon, Min Sook ^a   Kim, Sun Jung ^a   Lee, Su Young ^b   Jeong, Jeong Hae ^b   Lee, Eun Sook ^b   Kang, Han Sung ^b  

^a Dongguk University   (South Korea)

^b National Cancer Center   (South Korea)

Author keywords

Breast cancer; Methylation; Sulfotransferase

Indexed keywords

ARYL SULFOTRANSFERASE; SULT1A1 PROTEIN, HUMAN;

ARTICLE; BREAST TUMOR; CPG ISLAND; DNA METHYLATION; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC EPIGENESIS; GENETICS; HUMAN; PROMOTER REGION; TUMOR GENE;

ARYLSULFOTRANSFERASE; BREAST NEOPLASMS; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, NEOPLASM; HUMANS; PROMOTER REGIONS (GENETICS);

EID: 33644877840     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.1.27     Document Type: Article

References (20)

1. Osborne MP, Bradlow HL, Wong GY and Telang NT: Upregulation of estradiol C16 alpha-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk. J Natl Cancer Inst 85: 1917-1920, 1993.
2. Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA and Easton DF: A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 8: 843-854, 1999. (Pubitemid 29508718)
3. Coughtrie MW: Sulphation catalysed by the human cytosolic sulphotransferases - chemical defence or molecular terrorism? Hum Exp Toxicol 15: 547-555, 1996.
4. Falany CN: Sulfation and sulfotransferases. Introduction: changing view of sulfation and the cytosolic sulfotransferases. FASEB J 11: 1-2, 1997.
5. Weinshilboum RM, Otterness DM, Aksoy IA, Wood TC, Her C and Raftogianis RB: Sulfation and sulfotransferases 1. Sulfotransferase molecular biology: cDNAs and genes. FASEB J 11: 3-14, 1997. (Pubitemid 27076319)
6. Coughtrie MW, Sharp S, Maxwell K and Innes NP: Biology and function of the reversible sulfation pathway catalysed by human sulfotransferases and sulfatases. Chem Biol Interact 109: 3-27, 1998. (Pubitemid 28161098)
7. Gilissen RA, Bamforth KJ, Stavenuiter JF, Coughtrie MW and Meerman JH: Sulfation of aromatic hydroxamic acids and hydroxylamines by multiple forms of human liver sulfotransferases. Carcinogenesis 15: 39-45, 1994. (Pubitemid 24121622)
8. Chou HC, Lang NP and Kadlubar FF: Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s). Cancer Res 55: 525-529, 1995.
9. Dooley TP, Haldeman-Cahill R, Joiner J and Wilborn TW: Expression profiling of human sulfotransferase and sulfatase gene superfamilies in epithelial tissues and cultured cells. Biochem Biophys Res Commun 277: 236-245, 2000.
10. Hempel N, Wang H, Le Cluyse EL, McManus ME and Negishi M: The human sulfotransferase SULT1A1 gene is regulated in a synergistic manner by Sp1 and GA binding protein. Mol Pharmacol 66: 1690-1701, 2004. (Pubitemid 39564797)
11. Jones PA and Laird PW: Cancer epigenetics comes of age. Nat Genet 21: 163-167, 1999. (Pubitemid 29070360)
12. Kang JH, Kim SJ, Noh DY, Park IA, Choe KJ, Yoo OJ and Kang HS: Methylation in the p53 promoter is a supplementary route to breast carcinogenesis: correlation between CpG methylation in the p53 promoter and the mutation of the p53 gene in the progression from ductal carcinoma in situ to invasive ductal carcinoma. Lab Invest 81: 573-579, 2001. (Pubitemid 32298803)
13. Raftogianis RB, Wood TC, Otterness DM, van Loon JA and Weinshilboum RM: Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype. Biochem Biophys Res Commun 239: 298-304, 1997. (Pubitemid 27480360)
14. Nowell S, Ambrosone CB, Ozawa S, MacLeod SL, Mrackova G, Williams S, Plaxco J, Kadlubar FF and Lang NP: Relationship of phenol sulfotransferase activity (SULT1A1) genotype to sulfotransferase phenotype in platelet cytosol. Pharmacogenetics 10: 789-797, 2000. (Pubitemid 32042831)
15. Zheng W, Xie D, Cerhan JR, Sellers TA, Wen W and Folsom AR: Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 10: 89-94, 2001. (Pubitemid 32172425)
16. Lehmann U, Langer F, Feist H, Glockner S, Hasemeier B and Kreipe H: Quantitative assessment of promoter hypermethylation during breast cancer development. Am J Pathol 160: 605-612, 2002. (Pubitemid 34160338)
17. Issa JP: Aging, DNA methylation and cancer. Crit Rev Oncol Hematol 32: 31-43, 1999.
18. Toyooka S, Carbone M, Toyooka KO, Bocchetta M, Shivapurkar N, Minna JD and Gazdar AF: Progressive aberrant methylation of the RASSF1A gene in simian virus 40 infected human mesothelial cells. Oncogene 21: 4340-4344, 2002. (Pubitemid 34753842)
19. Graff JR, Herman JG, Myohanen S, Baylin SB and Vertino PM: Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J Biol Chem 272: 22322-22329, 1997. (Pubitemid 27382868)
20. Yan PS, Shi H, Rahmatpanah F, Hsiau TH, Hsiau AH, Leu YW, Liu JC and Huang TH: Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer. Cancer Res 63: 6178-6186, 2003. (Pubitemid 37255161)